2012•Jiangsu Medical JournalRequires access

Value of RUNX3 gene promoter methylation in diagnosis of non-small cellular lung cancer

Mingfeng Zheng

Open publisher page 0 citations

Abstract

Objective To investigate the value of RUNX3 gene promoter methylation in diagnosis of non-small cellular lung cancer(NSCLC). Methods The methylation of RUNX3 gene promoter was analyzed in 58 NSCLC tissues and tumor-adjacent normal lung tissues by methylation-specific-PCR. The correlation between methylation of RUNX3 gene promoter and clinicopathological characteristics was statistically analyzed as well.Results Twenty-six(44.8%) tissues with methylation of RUNX3 gene promoter in 58 NSCLC tissues was detected,which was significantly higher than 10(17.2%) tumor-adjacent normal lung tissues(P0.01).The methylation of RUNX3 gene promoter was closely relatedtoclinical stage,lymph node metastasis and differentiation degree of NSCLC(P0.05). Conclusion The high methylation rate of RUNX3 gene promoter exists in NSCLC tissues.The methylation of RUNX3 gene promoter is closely related to clinical stage,lymph node metastasis and differentiation degree and has an important significance in the diagnosis and evaluation of prognosis of NSCLC.

About this research paper

What this paper is about

Objective To investigate the value of RUNX3 gene promoter methylation in diagnosis of non-small cellular lung cancer(NSCLC). Methods The methylation of RUNX3 gene promoter was analyzed in 58 NSCLC tissues and tumor-adjacent normal lung tissues by methylation-specific-PCR. The correlation between methylation of RUNX3 gene promoter and clinicopathological characteristics was statistically analyzed as well.Results Twenty-six(44.8%) tissues with methylation of RUNX3 gene promoter in 58 NSCLC tissues was detected,which was significantly higher than 10(17.2%) tumor-adjacent normal lung tissues(P0.01).The methylation of RUNX3 gene promoter was closely relatedtoclinical stage,lymph node metastasis and differentiation degree of NSCLC(P0.05). Conclusion The high methylation rate of RUNX3 gene promoter exists in NSCLC tissues.The methylation of RUNX3 gene promoter is closely related to clinical stage,lymph node metastasis and differentiation degree and has an important significance in the diagnosis and evaluation of prognosis of NSCLC.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the value of RUNX3 gene promoter methylation in diagnosis of non-small cellular lung cancer(NSCLC). Methods The methylation of RUNX3 gene promoter was analyzed in 58 NSCLC tissues and tumor-adjacent normal lung tissues by methylation-specific-PCR. The correlation between methylation of RUNX3 gene promoter and clinicopathological characteristics was statistically analyzed as well.Results Twenty-six(44.8%) tissues with methylation of RUNX3 gene promoter in 58 NSCLC tissues was detected,which was significantly higher than 10(17.2%) tumor-adjacent normal lung tissues(P0.01).The methylation of RUNX3 gene promoter was closely relatedtoclinical stage,lymph node metastasis and differentiation degree of NSCLC(P0.05). Conclusion The high methylation rate of RUNX3 gene promoter exists in NSCLC tissues.The methylation of RUNX3 gene promoter is closely related to clinical stage,lymph node metastasis and differentiation degree and has an important significance in the diagnosis and evaluation of prognosis of NSCLC.

Key concepts: Methylation, Lung cancer, Promoter, Cancer research, Gene, Biology, DNA methylation, Molecular biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Value of RUNX3 gene promoter methylation in diagnosis of non-small cellular lung cancer — Research Paper | ScholarLens